Amino Acids
100/100
This product looks safe
- No ingredients exceed tolerable upper intake levels
- 22% of ingredients have research evidence
B
Label Compliance Grade
Product Label
Have a supplement label? Find it here.
Upload a photo of any supplement label to search our database of 92,312 products.
Label Data
2 Capsule(s)
Serving Size
90
Servings
Other Combinations
Product Type
22%
Evidence Coverage
Supplement Facts — Evidence Check
80 mcg
(27% DV)
✅ 2.7× RDA — within safe limits
📚 26 studies (Tier A: 0, B: 11)
20 mg
(133% DV)
✅ 1.8× RDA — within safe limits
📚 258 studies (Tier A: 6, B: 134)
2 mg
(100% DV)
✅ 2.2× RDA — within safe limits
📚 36 studies (Tier A: 0, B: 11)
48 mg
✅ Within RDA (0.1× RDA of 550 mg)
📚 36 studies (Tier A: 1, B: 7)
Glycine
357 mg
L-Proline
213 mg
L-Hydroxyproline
183 mg
L-Glutamic Acid
148 mg
L-Alanine
142 mg
114 mg
📊 Market median: 500.0mg (143 products)
86 mg
📊 Market median: 2000.0mg (63 products)
58 mg
📊 Market median: 500.0mg (159 products)
46 mg
📊 Market median: 17.4mg (161 products)
L-Valine
34 mg
L-Phenylalanine
28 mg
L-Threonine
28 mg
22 mg
📊 Market median: 17.4mg (161 products)
12 mg
📊 Market median: 500.0mg (193 products)
📚 7 studies — no high-quality reviews
L-Histidine
10 mg
L-Serine
50 mg
4 mg
📊 Market median: 500.0mg (223 products)
📚 22 studies (Tier A: 0, B: 1)
L-Cysteine
4 mg
GR8CF-77 Mineral Blend
200 mg
Other Ingredients
Gelatin Capsule
Magnesium Stearate
Silicon Dioxide
Label Claims — Verification
❓
All Other
❓
Structure/Function
All Other (98% of products)
Structure/Function (78% of products)
Nutrient (56% of products)
Target Groups
Adult (18 - 50 Years)
Product Information
📋 Directions for Use
Suggested Use: Take 2 capsules, 3 times daily.
⚠️ Warnings & Precautions
Caution: Not recommended for children under 10 years old.
Do not use this product if safety seal is broken.
Keep out of reach of children.
🧪 Formulation Notes
Hair, skin and weight loss support
Product Details
DSLD Entry Date
2020-06-24
Product Type
Other Combinations
Form
Capsule
Brand
Enriching Gifts
DSLD ID
228176
Data Updated
2026-04-11
Research Evidence
50
Research Sources
47
Avg Quality Score
28
Rct
13
Clinical Trial
5
Guideline
4
Systematic Review
A
Using a Novel Consensus-Based Chemoinformatics Approach to Predict ADMET Properties and Druglikeness of Tyrosine Kinase Inhibitors.
B
Australia and New Zealand consensus statement on the cardiovascular management of patients with chronic lymphocytic leukaemia treated with Bruton's tyrosine kinase inhibitors.
B
Branched-chain amino acid supplementation for improving growth and development in term and preterm neonates
B
[Clinical practice guideline on anaplastic lymphoma kinase-tyrosine kinase inhibitors for non-small cell lung cancer (2025 edition)].
B
[Chinese expert consensus on epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small cell lung cancer (2025 edition)].
B
Consensus Guideline for the Diagnosis and Treatment of Tyrosine Hydroxylase (TH) Deficiency.
B
Baseline-dependent effect of dopamine's precursor L-tyrosine on working memory gating but not updating
C
Attenuating Muscle Damage Biomarkers and Muscle Soreness After an Exercise-Induced Muscle Damage with Branched-Chain Amino Acid (BCAA) Supplementation: A Systematic Review and Meta-analysis with Meta-regression
Compare Similar Products
L-Tyrosine 500 mg
VitaCeutical Labs
100
Tyrosine
Vitabase
100
L-Tyrosine
Douglas Laboratories
100
L-Tyrosine 500 mg
Douglas Laboratories
100
N-Acetyl-L-Tyrosine 300
LifeLink
100